Bath & Body Works, Inc. $BBWI Shares Sold by Bank of New York Mellon Corp

Bank of New York Mellon Corp lessened its position in Bath & Body Works, Inc. (NYSE:BBWI) by 2.8% in the 1st quarter, Holdings Channel reports. The fund owned 2,450,925 shares of the company’s stock after selling 70,334 shares during the period. Bank of New York Mellon Corp’s holdings in Bath & Body Works were worth $45,759,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Geneos Wealth Management Inc. lifted its position in Bath & Body Works by 217.7% in the first quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock valued at $35,000 after purchasing an additional 801 shares during the period. Danske Bank A S acquired a new stake in shares of Bath & Body Works in the 3rd quarter valued at approximately $39,000. Global Retirement Partners LLC purchased a new stake in shares of Bath & Body Works in the fourth quarter valued at approximately $31,000. Activest Wealth Management acquired a new position in Bath & Body Works during the fourth quarter worth $32,000. Finally, Advisory Services Network LLC acquired a new position in Bath & Body Works during the third quarter worth $48,000. Hedge funds and other institutional investors own 95.14% of the company’s stock.

Bath & Body Works Stock Up 3.0%

NYSE BBWI opened at $19.92 on Friday. Bath & Body Works, Inc. has a fifty-two week low of $14.27 and a fifty-two week high of $32.32. The business has a fifty day moving average of $19.82 and a 200-day moving average of $20.44. The stock has a market cap of $4.02 billion, a price-to-earnings ratio of 5.60, a price-to-earnings-growth ratio of 1.91 and a beta of 1.38.

Bath & Body Works (NYSE:BBWI) last posted its quarterly earnings data on Wednesday, May 27th. The company reported $0.32 EPS for the quarter, topping analysts’ consensus estimates of $0.29 by $0.03. Bath & Body Works had a negative return on equity of 45.34% and a net margin of 10.03%.The firm had revenue of $1.38 billion during the quarter, compared to analysts’ expectations of $1.36 billion. During the same quarter last year, the business posted $0.49 EPS. The firm’s quarterly revenue was down 3.2% compared to the same quarter last year. Bath & Body Works has set its Q2 2026 guidance at 0.300-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. As a group, analysts anticipate that Bath & Body Works, Inc. will post 2.63 EPS for the current year.

Bath & Body Works Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, June 19th. Stockholders of record on Friday, June 5th were issued a dividend of $0.20 per share. The ex-dividend date was Friday, June 5th. This represents a $0.80 dividend on an annualized basis and a dividend yield of 4.0%. Bath & Body Works’s payout ratio is 22.47%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on the company. Barclays reduced their target price on Bath & Body Works from $25.00 to $23.00 and set an “equal weight” rating for the company in a report on Thursday, May 28th. Telsey Advisory Group reduced their price objective on shares of Bath & Body Works from $25.00 to $22.00 and set a “market perform” rating for the company in a research note on Thursday, May 28th. UBS Group decreased their price objective on shares of Bath & Body Works from $22.00 to $19.00 and set a “neutral” rating on the stock in a report on Wednesday, May 20th. TD Cowen upped their target price on shares of Bath & Body Works from $20.00 to $25.00 and gave the stock a “buy” rating in a research report on Thursday, May 28th. Finally, Piper Sandler assumed coverage on shares of Bath & Body Works in a report on Friday, May 15th. They issued a “neutral” rating and a $20.00 target price for the company. Three investment analysts have rated the stock with a Buy rating, fourteen have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $22.00.

About Bath & Body Works

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.